MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lewy bodies"

  • 2022 International Congress

    Sex Modulates Cognitive Association of Lewy Body Pathology

    E. Bayram, K. Wang, A. Tsai, D. Coughlin, I. Litvan (La Jolla, USA)

    Objective: To assess whether the association between Lewy body (LB) pathology stages and cognition differs for women and men Background: Progression of LB pathology is…
  • MDS Virtual Congress 2021

    Differential methylation signatures in Lewy body dementia

    P. Reho, TG. Beach, GE. Serrano, KL. Newell, HP. Easwaran, JC. Troncoso, O. Pletnikova, SW. Scholz (Bethesda, USA)

    Objective: This study aimed to compare the DNA methylome of Lewy body dementia (LBD) patients and healthy controls. Background: LBD is the second most common…
  • MDS Virtual Congress 2021

    Sex-Specific APOE ε4 Association with Cognition in Lewy Body Dementia

    E. Bayram, S. Scholz, I. Litvan (La Jolla, USA)

    Objective: To evaluate whether association between apolipoprotein E ε4 (APOE ε4) and cognition differ for men and women with pathologically-confirmed Lewy body dementia (LBD). Background:…
  • MDS Virtual Congress 2021

    Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

    J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)

    Objective: To identify the associations between Alzheimer Disease (AD) co-pathology and neuropsychiatric symptoms in Lewy body dementia (LBD). Background: Dementia with Lewy Bodies (DLB) and…
  • MDS Virtual Congress 2021

    Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

    S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

    Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…
  • MDS Virtual Congress 2020

    miRNA sequencing from routine colonic biopsies reveals an enrichment of submucosal hsa-miRNA-486-5p in Parkinson’s disease

    A. Kurz, R. Kumar, C. Wenk, B. Nordhoff, J. Schirra, S. Donakonda, G. Höglinger, K. Bötzel, L. Holdt, T. Koeglsperger (Munich, Germany)

    Objective: In the present work, we aimed to investigate the expression of microRNAs (miRNAs) in routine colonic biopsies obtained from patients with idiopathic Parkinson's disease…
  • MDS Virtual Congress 2020

    An agent-based model replicates the pathogenic spread of alpha-synuclein in mice

    S. Rahayel, B. Mišić, Y.Q Zheng, Z.Q Liu, A. Caputo, K. Luk, A. Dagher (Montreal, QC, Canada)

    Objective: To investigate the ability of a susceptible-infected-removed (SIR) agent-based model to predict the pathogenic spread of alpha-synuclein fibrils after injection in mice. Background: Parkinson’s…
  • MDS Virtual Congress 2020

    Difference in distribution between alpha-synuclein oligomers and Lewy bodies in Parkinson’s disease brain

    H. Sekiya, H. Kowa, Y. Hashimoto, M. Takata, R. Matsumoto, T. Toda (Kobe, Japan)

    Objective: To examine the distribution of alpha-synuclein (αSYN) oligomers in Parkinson’s disease (PD) brains and compare the distribution of αSYN oligomers and Lewy bodies. Background:…
  • MDS Virtual Congress 2020

    The exosomal a-syn filaments can be a novel biomarker of Parkinson’s disease

    Y. Ishiguro, T. Tsunemi, A. Yoroisaka, N. Hattori (Tokyo, Japan)

    Objective: This study is aimed to investigate whether the number of exosomes, the amount of total or exosomal a-synuclein (a-syn) filaments in serum can serve as…
  • MDS Virtual Congress 2020

    Microbiome from Parkinson’s patients shows an increase in polyamines metabolism and differentially expresses microbial bacterial taxa compared to aged-matched normal controls

    S. Melgar, N. Danso, C. Pena, J. Ahmed, S. Kumar, R. Kumar, C. Carlin, D. Linseman, D. Paredes (Denver, CO, USA)

    Objective: The goal of this study was to determine whether the microbiome from Parkinson’s disease (PD) has alterations in a) Polyamine metabolism and b) Expressed…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley